270 related articles for article (PubMed ID: 32422442)
1. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
Bounameaux H; Haas S; Farjat AE; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Schellong S; Mantovani LG; Prandoni P; Kakkar AK
Thromb Res; 2020 Jul; 191():103-112. PubMed ID: 32422442
[TBL] [Abstract][Full Text] [Related]
2. On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
Haas S; Farjat AE; Pieper K; Ageno W; Angchaisuksiri P; Bounameaux H; Goldhaber SZ; Goto S; Mantovani L; Prandoni P; Schellong S; Turpie AGG; Weitz JI; MacCallum P; Cate HT; Panchenko E; Carrier M; Jerjes-Sanchez C; Gibbs H; Jansky P; Kayani G; Kakkar AK;
TH Open; 2022 Oct; 6(4):e354-e364. PubMed ID: 36452204
[No Abstract] [Full Text] [Related]
3. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
4. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.
Bertoletti L; Gusto G; Khachatryan A; Quignot N; Chaves J; Moniot A; Mokgokong R
Thromb Haemost; 2022 Aug; 122(8):1384-1396. PubMed ID: 34983073
[TBL] [Abstract][Full Text] [Related]
6. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
9. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
10. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
[TBL] [Abstract][Full Text] [Related]
11. A Real-World Cost-Effectiveness Analysis of Rivaroxaban versus Vitamin K Antagonists for the Treatment of Symptomatic Venous Thromboembolism: Lessons from the REMOTEV Registry.
Kepka S; Cordeanu EM; Zarca K; Frantz AS; Ohlmann P; Andres E; Bilbault P; Durand-Zaleski I; Stephan D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676804
[No Abstract] [Full Text] [Related]
12. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
13. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
[TBL] [Abstract][Full Text] [Related]
14. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
[TBL] [Abstract][Full Text] [Related]
15. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
[TBL] [Abstract][Full Text] [Related]
16. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
17. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?
Cohen AT; Granziera S; Veronese N; Zoppellaro G
Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196
[TBL] [Abstract][Full Text] [Related]
18. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis.
Chaudhary R; Pagali S; Garg J; Murad MH; Wysokinski WE; McBane RD
J Am Geriatr Soc; 2020 Sep; 68(9):2021-2026. PubMed ID: 32441334
[TBL] [Abstract][Full Text] [Related]
19. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
Malec K; Broniatowska E; Undas A
Lupus; 2020 Jan; 29(1):37-44. PubMed ID: 31757182
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]